Cynosure Receives Approval to Market SculpSure® in South Korea
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Brean Capital Raises Price Target as Cynosure (CYNO) Delivers Strong 2Q Results
July 27, 2016 10:58 AM EDTBrean Capital reiterated a Buy rating on Cynosure (NASDAQ: CYNO), and raised the price target to $60.00 (from $54.00), following the company's 2Q earnings report. Revenue was $110.3 million vs. consensus of $101.3 million. The growth was driven primarily by product expansion in North America. Non-GAAP EPS came in... More
Northland Capital Markets Raises Price Target on Cynosure (CYNO) to $60 Following 2Q
July 27, 2016 10:41 AM EDTNorthland Capital Markets reiterated an Outperform rating on Cynosure (NASDAQ: CYNO), and raised the price target to $60.00 (from $55.00), following the company's 2Q earnings report. CYNO reported revenues of $110M, coming in ahead of the Street's $102M estimates. EPS of $0.27 was also above estimates.... More
